Grimes & Company’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Buy |
+18,163
| New | +$2.3M | 0.06% | 159 |
|
|
2025
Q1 | – | Sell |
-26,182
| Closed | -$3.46M | – | 387 |
|
|
2024
Q4 | $3.46M | Buy |
+26,182
| New | +$3.46M | 0.1% | 116 |
|
|
2022
Q4 | – | Sell |
-2,080
| Closed | -$243K | – | 300 |
|
|
2022
Q3 | $243K | Buy |
2,080
+2
| +0.1% | +$234 | 0.01% | 238 |
|
|
2022
Q2 | $244K | Hold |
2,078
| – | – | 0.01% | 239 |
|
|
2022
Q1 | $271K | Sell |
2,078
-682
| -25% | -$88.9K | 0.01% | 248 |
|
|
2021
Q4 | $421K | Buy |
2,760
+187
| +7% | +$28.5K | 0.02% | 215 |
|
|
2021
Q3 | $416K | Buy |
2,573
+78
| +3% | +$12.6K | 0.02% | 210 |
|
|
2021
Q2 | $408K | Buy |
2,495
+35
| +1% | +$5.72K | 0.02% | 211 |
|
|
2021
Q1 | $370K | Sell |
2,460
-83
| -3% | -$12.5K | 0.02% | 213 |
|
|
2020
Q4 | $385K | Buy |
+2,543
| New | +$385K | 0.02% | 203 |
|